Guillermo Torre Acquires 17,240 Shares of Cardiol Therapeutics Inc. (TSE:CRDL) Stock

Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Guillermo Torre bought 17,240 shares of the company’s stock in a transaction that occurred on Thursday, December 26th. The stock was purchased at an average cost of C$1.81 per share, with a total value of C$31,277.77.

Cardiol Therapeutics Price Performance

TSE:CRDL opened at C$1.89 on Friday. The stock has a market cap of C$132.07 million, a PE ratio of -4.30 and a beta of 0.70. The company has a quick ratio of 6.84, a current ratio of 2.39 and a debt-to-equity ratio of 1.07. The business’s 50-day simple moving average is C$2.29 and its two-hundred day simple moving average is C$2.64. Cardiol Therapeutics Inc. has a 52 week low of C$1.09 and a 52 week high of C$4.26.

About Cardiol Therapeutics

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.